The current price-to-earnings ratio for Boston Scientific stock as of Dec 20, 2024 is 72.91. This is calculated based on the current EPS of $1.22 and the stock price of $88.95 per share. The P/E ratio has increased by 21% from the past four quarters average of 60.4.
The average historical PE ratio of Boston Scientific for the last nine years is 92.81. The current PE ratio of 72.91 is 21% below the historical average. In the past nine years, BSX's PE ratio was at its highest in the Sep 2016 quarter at 396.67, when the stock price was $23.8 and the EPS was $0.06. The lowest value was in the Mar 2020 quarter, when it reached 10.59 with a price of $32.63 and an EPS of $3.08.
Maximum annual increase: 272.5% in 2017
Maximum annual decrease: -90.57% in 2018
Year | PE ratio | Change |
---|---|---|
2023 | 53.53 | -47.94% |
2022 | 102.82 | 67% |
2021 | 61.57 | N/A |
2020 | N/A | N/A |
2019 | 13.38 | -54.19% |
2018 | 29.21 | -90.57% |
2017 | 309.88 | 272.5% |
2016 | 83.19 | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
The current PE ratio of BSX is lower than the 3, 5 and 10-year averages.
BSX's PE ratio is higher than its peer stocks SYK and MDT. Boston Scientific's current PE ratio of 72.91 is above the average of its peers, which is 28.8.
Stock name | PE ratio | Market cap |
---|---|---|
EW Edwards Lifesciences Corp | 10.78 | $44.12B |
CNMD CONMED Corp | 16.04 | $2.12B |
MDT Medtronic plc | 24.63 | $103.9B |
TFX Teleflex Inc | 35.21 | $8.27B |
SYK Stryker Corp | 38.66 | $138.99B |
MMSI Merit Medical Systems Inc | 47.45 | $5.72B |
BSX Boston Scientific Corp | 72.91 | $131.1B |
ANGO Angiodynamics Inc | N/A | $361.24M |
As of Dec 20, 2024, BSX stock has a price to earnings ratio of 72.91.
As an average over the last 3 years, BSX stock has a PE ratio of 74.18.
As an average over the last 5 years, BSX stock has a PE ratio of 73.1.
Over the last nine years, the quarterly PE ratio reached a historic high of 396.67 in the Sep 2016 quarter.
The current price to earnings ratio of BSX is 21% lower than the 9-year historical average.
A company with a higher PE ratio may indicate that the market has higher growth expectations for the company's future earnings or profitability.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Dec 20, 2024), Boston Scientific's stock price is $88.95. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.22. Therefore, Boston Scientific's P/E ratio for today is 72.91. PE RATIO(72.91) = STOCK PRICE($88.95) / TTM EPS($1.22)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.